Global Electroceuticals / Bioelectric Medicine Market to Reach US$20.8 Billion by the Year 2026
Abstract: Global Electroceuticals / Bioelectric Medicine Market to Reach US$20. 8 Billion by the Year 2026 . Electroceuticals have a lot of potential to become the principal method of medical treatment.
New York, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Electroceuticals / Bioelectric Medicine Industry" - https://www.reportlinker.com/p06219496/?utm_source=GNW
The relatively new area of Bioelectric medicine/Electroceutical devices has provided a new approach to treatment of chronic illnesses. As the treatment is through electrical impulses rather than drugs, there is less chance of major side effects and further, the therapy also results in the body producing endorphins which gives relief from pain. This new form of treatment through devices can address resynchronization, defibrillation and pacemaker application normally used in the field of cardiology. The technology also has its use in treating heart failure, atrial fibrillation, diseases related to the coronary artery, myocarditis, resistant hypertension, ventricular as well as atrial tachyarrhythmias, pulseless electrical activity and refractory angina. The heightened pace of research in the area of bioelectric medicine is also likely to boost future business. Companies are exploring on non-surgical methods of implantation and improved features of electrode technologies for making the embedding process of the biomedicines possible through the skin. Such non-invasive electroceutical devices also show promising future due to the comfort factor attached to them for patients who do not have to incur surgical costs and inconvenience of post-surgery recovery.
Amid the COVID-19 crisis, the global market for Electroceuticals / Bioelectric Medicine estimated at US$15 Billion in the year 2020, is projected to reach a revised size of US$20.8 Billion by 2026, growing at a CAGR of 5.6% over the analysis period. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is projected to grow at a 6.5% CAGR to reach US$13.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cochlear Implants segment is readjusted to a revised 4.6% CAGR for the next 7-year period. This segment currently accounts for a 14.8% share of the global Electroceuticals / Bioelectric Medicine market. Cardiac diseases have increased globally, fueling the market growth of the cardiac pacemaker. A cardiac pacemaker when placed in the chest uses electrical pulses to control arrhythmia or abnormal heart rhythm of patients. Cochlear implant is one of the most common electroceutical for substituting damaged ear part and providing hearing ability.
The U.S. Market is Estimated at $6.9 Billion in 2021, While China is Forecast to Reach $1.7 Billion by 2026
The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$6.9 Billion in the year 2021. The country currently accounts for a 44.6% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.7 Billion in the year 2026 trailing a CAGR of 6.7% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$1.8 Billion by the end of the analysis period. North America, with its well-developed healthcare infrastructure, is widespread adopter of new technologies, thus providing favorable growth outlook for electroceuticals/ bioelectric medicine technology. The growing number of people suffering from a range of chronic medical conditions like cardiovascular disease, neurological ailments, cancer, arrhythmia, and hearing loss are propelling growth in the region. The presence of leading medical device makers including Boston Scientific Corporation, Medtronic and BIOTRONIK in the region augurs well for the market. In Europe, the substantial infrastructure for healthcare, high demand for innovative medical solutions and the presence of several healthcare majors in Germany, the UK, Switzerland, and France, are presenting robust growth opportunities.
Spinal Cord Stimulators Segment to Reach $2.9 Billion by 2026
A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord. Spinal cord stimulators consist of electrodes, or leads, placed in the epidural space around the spinal cord. The electrodes are connected to and powered by a pulse generator or batteries. In the global Spinal Cord Stimulators segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$2.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$205.4 Million by the year 2026.
Select Competitors (Total 50 Featured)
Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corporation
Cochlear Ltd.
electroCore, Inc.
LivaNova PLC
Medtronic PLC
Nevro Corp.
Second Sight Medical Products, Inc.
Sonova Holding AG
Read the full report: https://www.reportlinker.com/p06219496/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021?
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
COVID-19 Impact on the Electroceuticals/Bioelectric Medicine
Market
Researchers Demonstrate Role of Electroceutical Fabric in
Eradicating Coronaviruses
An Introduction to Electroceuticals/Bioelectric Medicine
Using Electrical Stimulation in Nerves: Historical Perspective
Types of Electroceutical Devices
Major Applications of Electroceuticals/Bioelectric Medicine
Global Market Prospects & Outlook
Implantable Electroceutical Devices: The Leading Category
Cardiac Pacemakers & Implantable Cardioverter Defibrillators
Segment Lead the Global Market
Developed Regions Lead, Developing Economies to Spearhead Growth
Competition
EXHIBIT 2: Global DBS Market Share Breakdown of Revenues by
Leading Players: 2020E
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Electroceutical/Biomedical Medicine Emerges to Overcome
Drawbacks of Traditional Treatments
Faster Healing: A Key Benefit Fueling Growth in
Electroceuticals Market
Ineffectiveness of Drug Therapy and Issues with Side Effects
Present Opportunities for Electroceuticals Market
Disease-specific Electroceuticals to Drive Future Gains
Aging Global Population Raises Risk of Neurological &
Cardiovascular Diseases, Fueling Market Outlook
EXHIBIT 3: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 4: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Growing Prevalence of Cardiovascular Diseases and Need for
Effective Treatments Supports Market Growth
EXHIBIT 5: Global Annual Medical Cost of CVD in US$ Billion:
2010, 2015, 2020, 2025 and 2030
EXHIBIT 6: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others
EXHIBIT 7: Leading Causes of Death Worldwide: 2019
Cardiac Pacemaker: A Solution for Cardiac Arrythmias
Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
Technological Advancements to Transform Cardiac Pacemaker
Devices Marketplace
Rising Incidence of Neurological Disorders and Need for Novel
Therapies to Spur Market Growth
EXHIBIT 8: Annual Incidence of Adult-Onset Neurologic Disorders
in the US
Bioelectronic Medicine Emerges as a Vital Therapy for Targeted
Neuromodulation
Deep Brain Stimulators: Useful in Treatment of
Neurodegenerative Diseases
EXHIBIT 9: Global Alzheimer’s Prevalence by Age Group
EXHIBIT 10: Diagnosed Prevalence Cases of Parkinson?s Disease
in Select Countries
Select Available Deep Brain Stimulation Devices Available in
the Market
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve
Stimulation Devices
EXHIBIT 11: Epilepsy Incidence Worldwide by Type: Percentage
Breakdown for Idiopathic and Symptomatic Epilepsy by Type:
(2020)
EXHIBIT 12: Symptomatic Epilepsy Incidence: Percentage of
Incidence by Type for 2020
Developments in Vagal Nerve Stimulation (VNS) Devices
Spinal Cord Injuries Propel the Demand for Spinal Cord
Stimulation Devices
TENS (Transcutaneous electrical nerve stimulation devices)
Market Witnesses Rapid Growth
Biodegradable Devices For Nerve Recovery
Bioelectric Medicine: A Potential Treatment Approach for
Crohn?s Disease
Growing Prevalence of Hearing Loss Boosts Opportunities in the
Cochlear Implants Market
EXHIBIT 13: Global Prevalence (%) by Severity of Hearing Loss
Vendors Focus on Innovations in Cochlear Implants
Developing Economies to Boost Long-term Prospects
Electroceutical Acupuncture: Emerging Pain Therapy
Neuropuncture - The Electroceutical Technology to Treat Pain &
Injury
Bioelectronics Technology Fuels Advances in Next-Generation of
Device Therapeutics
Market Benefits from the Significant Advantages of Bioelectronics
Overcoming the Challenges
Increasing Research Activity in Bioelectric Medicine Drives
Market Opportunities
Market Poised to Benefit from the Development of New
Bioelectronic Devices
Technological Advancements to Boost Growth Prospects
Rise in Healthcare Expenditure to Drive Growth
EXHIBIT 14: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021 & 2023
EXHIBIT 15: Elderly Healthcare Expenditure as a % of GDP in the
US, Europe and Japan for 1970, 2010 and 2050
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Electroceuticals /
Bioelectric Medicine by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Geographic Region - Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets for Years 2012,
2021 & 2027
Table 4: World Current & Future Analysis for Cardiac Pacemakers &
ICDs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR
Table 5: World Historic Review for Cardiac Pacemakers & ICDs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 6: World 15-Year Perspective for Cardiac Pacemakers &
ICDs by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027
Table 7: World Current & Future Analysis for Cochlear Implants
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR
Table 8: World Historic Review for Cochlear Implants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 9: World 15-Year Perspective for Cochlear Implants by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 10: World Current & Future Analysis for Spinal Cord
Stimulators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR
Table 11: World Historic Review for Spinal Cord Stimulators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 12: World 15-Year Perspective for Spinal Cord Stimulators
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 13: World Current & Future Analysis for Deep Brain
Stimulators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2020
through 2027 and % CAGR
Table 14: World Historic Review for Deep Brain Stimulators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 15: World 15-Year Perspective for Deep Brain Stimulators
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 16: World Current & Future Analysis for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR
Table 17: World Historic Review for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 18: World 15-Year Perspective for Other Products by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 19: World Current & Future Analysis for Hospitals,
Clinics & ASCs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Hospitals, Clinics & ASCs
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 21: World 15-Year Perspective for Hospitals, Clinics &
ASCs by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2021 & 2027
Table 22: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2020 through 2027
and % CAGR
Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 25: USA Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 26: USA Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 27: USA 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 28: USA Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
CANADA
Table 31: Canada Current & Future Analysis for Electroceuticals/
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 32: Canada Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 33: Canada 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 34: Canada Current & Future Analysis for Electroceuticals/
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 35: Canada Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 36: Canada 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
JAPAN
Table 37: Japan Current & Future Analysis for Electroceuticals/
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 38: Japan Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 39: Japan 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 40: Japan Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 41: Japan Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 42: Japan 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
CHINA
Table 43: China Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 44: China Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 45: China 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 46: China Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 47: China Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 48: China 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
EUROPE
Table 49: Europe Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2020 through 2027 and
% CAGR
Table 50: Europe Historic Review for Electroceuticals /
Bioelectric Medicine by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Revenues in US$ Million for Years 2012 through 2019 and
% CAGR
Table 51: Europe 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Geographic Region - Percentage
Breakdown of Value Revenues for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2012, 2021 & 2027
Table 52: Europe Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 53: Europe Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 54: Europe 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 55: Europe Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 56: Europe Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 57: Europe 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
FRANCE
Table 58: France Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 59: France Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 60: France 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 61: France Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 62: France Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 63: France 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
GERMANY
Table 64: Germany Current & Future Analysis for
Electroceuticals / Bioelectric Medicine by Product - Cardiac
Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators,
Deep Brain Stimulators and Other Products - Independent
Analysis of Annual Revenues in US$ Million for the Years 2020
through 2027 and % CAGR
Table 65: Germany Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 66: Germany 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 67: Germany Current & Future Analysis for
Electroceuticals / Bioelectric Medicine by End-Use - Hospitals,
Clinics & ASCs and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 68: Germany Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 69: Germany 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
ITALY
Table 70: Italy Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 71: Italy Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 72: Italy 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 73: Italy Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs
and Other End-Uses - Independent Analysis of Annual Revenues in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 74: Italy Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 75: Italy 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
UNITED KINGDOM
Table 76: UK Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products - Independent Analysis of Annual
Revenues in US$ Million for the Years 2020 through 2027 and %
CAGR
Table 77: UK Historic Review for Electroceuticals / Bioelectric
Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear
Implants, Spinal Cord Stimulators, Deep Brain Stimulators and
Other Products Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 78: UK 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by Product - Percentage Breakdown of Value
Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants,
Spinal Cord Stimulators, Deep Brain Stimulators and Other
Products for the Years 2012, 2021 & 2027
Table 79: UK Current & Future Analysis for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 80: UK Historic Review for Electroceuticals / Bioelectric
Medicine by End-Use - Hospitals, Clinics & ASCs and Other
End-Uses Markets - Independent Analysis of Annual Revenues in
US$ Million for Years 2012 through 2019 and % CAGR
Table 81: UK 15-Year Perspective for Electroceuticals /
Bioelectric Medicine by End-Use - Percentage Breakdown of Value
Revenues for Hospitals, Clinics & ASCs and Other End-Uses for
the Years 2012, 2021 & 2027
REST OF EUROPE
Table 82: Rest of Europe Current & Future Analysis for
Electroceuticals / Bioelectric Medicine by Product - Cardiac
Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators,
Deep Brain Stimulators and Other Products - Independent
Analysis of Annual Revenues in US$ Million for the Years 2020
through 2027 and % CAGR
Table 83: Rest of Europe Historic Review for Electroceuticals /
Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 84: Rest of Europe 15-Year Perspective for
Electroceuticals / Bioelectric Medicine by Product - Percentage
Breakdown of Value Revenues for Cardiac Pacemakers & ICDs,
Cochlear Implants, Spinal Cord Stimulators, Deep Brain
Stimulators and Other Products for the Years 2012, 2021 & 2027
Table 85: Rest of Europe Current & Future Analysis for
Electroceuticals / Bioelectric Medicine by End-Use - Hospitals,
Clinics & ASCs and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 86: Rest of Europe Historic Review for Electroceuticals /
Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Million for Years 2012 through 2019 and % CAGR
Table 87: Rest of Europe 15-Year Perspective for
Electroceuticals / Bioelectric Medicine by End-Use - Percentage
Breakdown of Value Revenues for Hospitals, Clinics & ASCs and
Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Table 88: Asia-Pacific Current & Future Analysis for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06219496/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
